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Abstract
Noradrenergic neurons in the caudal ventrolateral medulla (CVLM; A1 group) contribute to cardiovascular regulation. The
present study assessed whether specific lesions in the A1 group altered the cardiovascular responses that were evoked by
hypertonic saline (HS) infusion in non-anesthetized rats. Male Wistar rats (280–340 g) received nanoinjections of
antidopamine-b-hydroxylase-saporin (A1 lesion, 0.105 ng.nL21) or free saporin (sham, 0.021 ng.nL21) into their CVLMs. Two
weeks later, the rats were anesthetized (2% halothane in O2) and their femoral artery and vein were catheterized and led to
exit subcutaneously between the scapulae. On the following day, the animals were submitted to HS infusion (3 M NaCl,
1.8 ml N kg21, b.wt., for longer than 1 min). In the sham-group (n = 8), HS induced a sustained pressor response (DMAP:
3563.6 and 1161.8 mmHg, for 10 and 90 min after HS infusion, respectively; P,0.05 vs. baseline). Ten min after HS
infusion, the pressor responses of the anti-DbH-saporin-treated rats (n = 11)were significantly smaller(DMAP: 1861.4 mmHg;
P,0.05 vs. baseline and vs. sham group), and at 90 min, their blood pressures reached baseline values (261.6 mmHg).
Compared to the sham group, the natriuresis that was induced by HS was reduced in the lesioned group 60 min after the
challenge (19665.5 mM vs. 26267.6 mM, respectively; P,0.05). In addition, A1-lesioned rats excreted only 47% of their
sodium 90 min after HS infusion, while sham animals excreted 80% of their sodium. Immunohistochemical analysis
confirmed a substantial destruction of the A1 cell group in the CVLM of rats that had been nanoinjected withanti-DbH-
saporin. These results suggest that medullary noradrenergic A1 neurons are involved in the excitatory neural pathway that
regulates hypertensive and natriuretic responses to acute changes in the composition of body fluid.
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Introduction
Sodium (Na+) cationsare the main ions for determining the
osmolarity and volume of the extracellular compartment of
complex organismsdue to their concentration and reduced
permeability through plasmatic cell membranes. Variations in
the concentration of these ions can cause an osmotic flux between
intra- and extracellular compartments, which can affect all
perfused tissues and may alter the volume, metabolism, and
function of cells [1].
The central nervous system (CNS) detects variations in the
volume, tonicity, and composition of the extracellular compart-
ment through various peripheral and central receptors [2–5].
Once detected,these changes trigger a set of responses that
reestablish physiological conditions. In mammals, a slight increase
of 1–2% in the osmolarity of the plasma or a reduction of 8–10%
in the volume of the extracellular compartment is sufficient to
induce water intake [6,7]. As for vegetative adjustments, an
increase in the concentration of plasma sodium levels reducesthe
sympathetic outflow to renal nerves [8–12] andstimulatesrenal
vasodilation [3,11,13–17], thereby resulting in natriuresis [18–21]
and diuresis [2,22]. Humoral responses also contribute to the
regulation of osmolarity by inhibiting the secretion of renin [23],
atrial natriuretic peptides (ANP) [24–28], oxytocin (OT) [29–32],
and vasopressin [32].
Experimental evidenceindicates that A1 noradrenergic neurons,
which are localized in the caudal ventrolateral medulla (CVLM),
play a key role in regulating cardiovascular homeostasis
[12,17,33]. Studies on the gene expression of immediate activation
genes showed that the A1 neuronal group was recruited by
increasing osmolarity or plasmatic volume [34–37]. Moreover,
important rolesfor the A1 noradrenergic neurons on renal
vasodilatation and sympathoinhibition that is induced by hyper-
natremia have been shown [12,17].
Neuroanatomical studies have demonstrated that the A1
noradrenergic neurons compose the central circuitry ofthe
baroreflex and cardiopulmonary reflexes [38–40]. These neurons
are reciprocally connected to hypothalamic structures that are
involved in the control of cardiovascular, renal and neuroendo-
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e73187
crine functions [41–48]. Thus, A1neuron projections to dience-
phalic regions represent an important link in the neural circuits
that control body fluid homeostasis.
In the present study, we sought to evaluate the involvement
ofthe A1 neuronal group in the cardiovascular and renal responses
that were induced by acute hypernatremiain non-anesthetized
rats. After damagingA1 noradrenergic neurons by nanoinjecting
anti-dopamine beta hydroxylase (DbH)–saporin into the CVLM,
we measured the cardiovascular responses and renal excretions
that were induced by hypertonic saline (HS) infusion.
Results
Lesions of the medullary catecholaminergic
neuronsinduced by nanoinjections of anti-DbH–saporin
into the CVLM
TH-positive neurons are found within the ventrolateral medulla
(VLM) and the nucleus of the solitary tract (NTS) from positions of
approximately 1900 mm caudal to 1900 mm rostral to the obex
(Figures 1 and 2). In saporin-treated animals (sham; n= 8), tyrosine
hydroxylase (TH)-positive neurons in the VLM between 200 mm
and 1900 mm caudal to the obex averaged approximately 25 cells
per section (A1 neurons). In rats that were treated with bilateral
nanoinjections of anti-DbH-saporin into their CVLM (n= 11), the
number of TH-positive neurons that were caudal to the obex was
reduced to approximately four cells per section. In this region,
which encompasses the area of the A1 noradrenergic neurons, the
number of TH-positive neurons was reduced by 81% when
compared tosaporin-treated animals (Figures 1 and 2).
Nanoinjections of anti-DbH–saporin within the CVLM did not
reduce the number of TH-immunopositive cells in the region that
was located between 200 mm caudal and 1900 mm rostral to the
obex (i.e., the region encompassing the C1 cell group; Figures 1
and 2). No significant changes in the number of TH-immunopo-
sitive cells (reduction of 0%; Figures 1 and 2) in the A2 or C2 cell
groups of the NTS (between 1900 mm caudal to 1900 mm rostral
to the obex) were seen.
The Dot Blot technique, which was performed using samples of
median preoptic nuclei (MnPO), showed that nanoinjections of
anti-DbH-saporin in the CVLM reduced TH levels in the MnPO
(Figure 3). This finding reveals that lesions in A1 were effective in
altering the A1–MnPO noradrenergic pathway.
Effects of A1lesions on the control ofthe baroreflex and
chemoreflex
The baseline values of body weight (b.wt.), mean arterial
pressure (MAP) and heart rate (HR) that were sampled before the
infusion of HS are shown in Table 1. When compared with the
control, animals that were nanoinjected with anti-DbH-saporin
presented a basal tachycardia (HR: 396613.4 vs. 34368.4 bpm;
P,0.05). Other values were similar to those of the sham and A1-
lesioned rats.
The sensitivity of the baroreceptor reflexes, as evaluated by
phenylephrine infusions, was not different between the sham
(22.160.07 bpm N mmHg21; n = 8; Figure 4 A) and A1-lesioned
(22.160.02 bpm N mmHg21; n = 7; Figure 4 A) groups.
Figures 4 B and C present the mean maximal changes in the
MAP and HR that wererecorded during the chemoreflex test, and
no differences inthe MAP (DMAP: 6965.3 vs. 6365.1 mmHg
mmHg) and HR (DHR: 2220633.4 vs. 2198621.2 bpm)
responses between A1-lesioned (n= 7) and sham (n= 8) rats,
respectively, were evident.
Effects of A1 lesions on the cardiovascular responses that
are caused by hypertonic saline infusions
In sham animals (n = 8; Figures 5 A and 6 A), HS infusions
caused a sustained pressor response (DMAP: 3663 and
1161.8 mmHg, at 10 and 90 min, respectively; P,0.05 vs.
baseline; n = 8). In anti-DbH-saporin-treated rats (n = 11; Figure 5
B and 6 A), pressor responses that were caused by HS
infusionswere attenuated (1861.4 and 261.6 mmHg, at 10 and
90 min after HS, respectively; P,0.05 vs. sham). In both groups,
sodium overload triggered bradycardia, which was evident 10 min
after HS (Figures 5 and 6 B; P,0.05 vs. baseline). However, the
range of this HS-induced negative chronotropy was greater in the
A1-lesioned group(DHR: 238610.3 vs. 26169.5 bpm; P,0.05)
than in the sham group. In both groups,it was possible to observe
heartbeat values that were similarto the baseline value approxi-
mately 30 min after HS infusion(Figure 5B).
Effects of HS infusion on plasma sodium and blood
hemoglobin concentrations
Plasma sodium and hemoglobin outcomes were determined in
sham and A1-lesioned rats before and after HS infusion. Baseline
plasma sodium concentrations were similar in the sham
(140.860.5 mM; n= 6; Figure 7 A) and A1-lesioned rats
(140.660.3 mM; n=6; Figure 7 A) 10 min after HS infusion,
and plasma sodium levels increased similarly in both groups
(146.760.9 mM and 146.960.5 mM in sham and A1-lesioned
rats, respectively; Figure 7 A). Interestingly, the sodium concen-
tration in anti-DbH-saporin-treated animals remained higher than
that of the sham group throughout the experimental trial(Figure 7
A), and a significantincrease in the blood hemoglobin levels in A1-
lesioned rats was observed 90 min after HS infusion (103.361.6%
vs. 98.861.2%, A1-lesioned vs. sham rats, respectively; P,0.05;
Figure 7 B).
Effects of HS infusion on urinary excretion
Urine collectionduring the experiments showed that hypertonic
saline increased the urinary volume of sham (n= 6) and anti-DbH-
saporin-treated rats (n = 6; Figure 8 A), and this effect was
enhanced 90 min after HS infusion (3.8560.2 and 4.3860.2 ml,
sham and A1-lesioned, respectively; P,0.05 vs. baseline). A1-
lesioned rats presented lower urinary sodium concentrations
(212.0967.1 mM, 90 min after HS infusion; Figure 8 B) and less
cumulative urinary sodium (0.9060.05 mmol, 90 min after HS
infusion; Figure 8 C) than the sham group (292.066.8 mM,
90 min after HS infusion; 1.1260.07 mmol, 90 min after HS
infusion, respectively; Figures 8 B and C). While sham animals
excreted 80% of their sodium, A1-lesioned rats excreted only 47%
of their sodium after 90 min of HS infusion. Overall, these results
indicate a lower capacity of A1-lesioned rats to excrete sodium.
Discussion
Our most important findings demonstrated that lesionsin the A1
group caused the following: i)modification of the A1 – MnPO
noradrenergic pathway; ii)an increase in the resting heart rate; iii)
noeffect on baroreflexesor chemoreflexes; iv) an attenuated
hypertensive response to hypertonic saline infusion; and v) a
reduced ability to recover physiological osmolality by lowering
sodium excretion.
Previous studies have indicated that A1 noradrenergic neurons
are involved in the regulation of body fluid homeostasis
[12,17,33]. Whether these neurons play a role in organizing
cardiovascular and renal responsesthat are induced by changes in
the volume or composition of the extracellular compartment is
A1 Noradrenergic Cells and Body Fluid Homeostasis
PLOS ONE | www.plosone.org 2 September 2013 | Volume 8 | Issue 9 | e73187
unclear. In this regard, our results pioneered the field in revealing
that the A1 plays a pivotal role in recovering cardiovascular and
renal homeostasis after hypertonic infusion. The present study
provides the following new key observations: i) the pressor
response to hypernatremia is attenuated in A1-lesioned rats; and
ii) A1 noradrenergic neuron lesions slow the mechanisms of
sodium excretion that are induced during acute hypernatremia in
non-anesthetized rats. Thesefindings support the idea thatA1
neurons serve as a part of a neural pathway that is involved in the
control of cardiovascular and renal responses that are induced by
acute changes in the sodium concentration of the plasma. These
renal outcomes exemplify the involvement of the A1 in the
regulation of renal sodium excretion.
The present study demonstrates that nanoinjections of anti-
DbH–saporin into the CVLM of rats produced an extensive
depletion of the catecholaminergic cell population. Our data
further show a massive lesion of the A1 catecholaminergic cell
group because bilateral nanoinjections of anti-DbH–saporin
induced a marked loss (81%) of TH-containing neurons(within
1.9 mm to 0.2 mm caudal to the obex). In addition, no significant
changes in the catecholaminergic neurons of the rostral ventro-
lateral medulla(RVLM; C1 group; 10%) and NTS (A2 group;
,0%) regions were seen, which indicates that the adopted method
was effective and specific to damaged A1 neurons.
Previous reports support the assertion that a loss in immuno-
reactivity is indicative of neuronal death [17,49,50]. The
mechanism of specific internalization of anti-DbH–saporin implies
that only cells synthesizing DbH can take up the conjugated toxin.
It has been postulated that the somatodendritic exocytosis of
catecholaminesin catecholaminergic neurons resulted in the
exposure of DbH and, therefore, the possible internalization of
the anti-DbH-saporin complex via their soma and/or dendrites. It
is not likely that the noradrenergic neurons survived because
saporin acts by blocking the ribosomal 60S subunit to inhibit
protein synthesis.
Wrenn et al. [51] reported a lack of TH or DbH-cells 9 months
after intracerebroventricular injections of anti-DbH–saporin, thus
demonstrating the irreversible effects of this substance. Similar
results were obtained in a recent study in which nanoinjection of
anti-DbH–saporin into the CVLM depleted approximately 79%
of A1 noradrenergic neurons within this region [17]. Furthermore,
in the present study, the A1 neuron lesions revealed a decrease in
the levels of the TH enzyme in MnPO, which suggeststhat damage
in the CVLM to MnPO noradrenergic pathway occurred. These
Figure 1. Medullary catecholaminergic neurons. Photomicrographs taken at 3 levels of the medulla showing TH-immunoreactive cells in the
NTS (A2 noradrenergic neurons), CVLM (A1 noradrenergic neurons) and RVLM (C1 adrenergic neurons) in rats that were nanoinjected with
unconjugated saporin (sham) or anti-DbH-saporin. Arrows indicate TH-positive cells, and the scale bar is equal to 50 mm.
doi:10.1371/journal.pone.0073187.g001
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results indicate the efficacy of anti-DbH-saporin in the selective
destruction of noradrenergic neurons.
Studies have demonstrated that the noradrenergic A1 neurons
that receive inputs from baroreceptors and cardiopulmonary
receptors [38–40] project to the diencephalic structures that are
involved in regulating thecirculating volume. For example,
neuroanatomical studies provided consistent evidencethatMnPO
and paraventricular hypothalamus(PVN)receiveddense noradren-
ergic inputs [41–48]. Nearly 80% of the A1 noradrenergic neurons
of the CVLM region project directly to the PVN and MnPO [48].
Accordingly, functional in vivo electrophysiology assessments have
demonstrated that these noradrenergic projections from the A1 to
the hypothalamic regions are mostly excitatory [46,47,52–56].
Using extracellular recordings of PVN neurons, Saphier [46]
demonstrated that electrical stimulation ofthe A1 region excited
most of the magnocellular oxytocin- and vasopressin-excreting
PVN neurons. Similarly, Tanaka et al. [56] described that
electrical stimulation of the A1region promoted excitation of
MnPO neurons that projected to the PVN viathe alpha-1 and
alpha-2 adrenoreceptors. This evidencestrongly suggests an
excitatory noradrenergic projection from A1 to PVN and MnPO,
which are mediated by alpha-adrenergic receptors.
Empirical evidencehasshown the involvement of A1 and MnPO
in cardiovascular regulation, and current data showed that A1
lesions and a decrease in TH levels in the MnPO did not change
the baseline levels of mean arterial pressure. These results are in
full agreement with those of Pedrino et al. [12,17], who also
reported unaltered baseline values of MAP between sham and A1-
lesioned rats. Moreover, in the present study, the baseline
tachycardiathat wasfound in A1-lesioned rats indicatedthe contri-
Figure 2. Lesions of A1 noradrenergic neurons after nanoinjections of anti-DbH-saporin into the CVLM.The number and average (mean
6 S.E.M.) of TH-positive cells in 40-mm-thick sections of the dorsal (A) and ventrolateral medulla (B). Sections from animals that were submitted to A1
lesions or sham were taken from 1.9 mm rostral to the obex to 1.9 mm caudal to the obex. Bilateral nanoinjections of anti-DbH-saporin into the
CVLM produced a loss of TH-containing neurons in this area (A1 group, loss = 81%). However, in the RVLM (C1 group, loss = 10%) and NTS (A2/C2
groups, loss , 0%), this loss was either decreased or not evident, respectively. { compared with sham, p,0.05.
doi:10.1371/journal.pone.0073187.g002
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bution of this medullary areato the control of the resting HR.
Previous studies did not report this baseline tachycardia [12,17];
however, in those studies, the animals were anesthetized. We
hypothesize that A1 neuronsmay directly or indirectly influence
hypothalamic pathways that govern the baseline heart rate. As
shown in this report, it is not unlike to suggest that these pathways
may be the same responsible for slowing sodium excretion to HS
infusion. This idea seems plausible because osmoreceptorsmodu-
late hypothalamic regions activitythat control renal and cardiac
sympathetic supplies, such as the PVNand MnPO [6].
The baroreflex and chemoreflex are important mechanisms that
are used to recover homeostasis after changes in extracellular
volume and composition occur [10,26,57]. Previous studies
demonstrated that the hypertension that was induced by HS was
significantly higher in sinoaortic,denervated rats [10]. Moreover,
the bradycardia, which was induced by HS infusion,wasabolished,
indicating the involvement of the baroreflex in this response [58].
In spite of the differential MAP and HR responses to HS infusion
in A1-lesionedanimals, we found a preservation of the baroreflex
and chemoreflex, which suggests that other mechanisms, possibly
supramedullary,underliethe differences in the pressor and brady-
cardic responses in A1-lesioned rats that were infused with HS.
However, this idea must be further investigated.
Consistent with previous results using the same protocol [28], in
the present study,HS infusion induced an increase in plasma
sodium levels without changing the blood hemoglobin concentra-
tion in sham animals, and this treatment resulted in a slight
increase in A1-lesioned rats. Therefore, it is conceivable that
cardiovascular adjustments that are induced by HS infusion, as
described in the present study, are due to the increased sodium
concentration rather than secondary to volume expansion.
Many efforts have been attempted to understand the mecha-
nisms that are involved in the cardiovascular responses to HS
infusion [10,15,17,18]. Similar to the resultsthat were obtained in
the present study, HS infusion caused hypertension in intact rats
[10,16,49,59,60]. The pressor responses appeared to be due to an
increase in lumbar sympathetic nerve activity and vasopressin
release [10,59,60]. In this study, we observed that A1 lesions
attenuated the increase in blood pressure that was caused by HS.
We suppose thatA1-lesioned rats present a lower capacity to
release vasopressin. As mentioned before, Saphier [46] demon-
strated that electrical stimulation of the A1 region excited most of
the magnocellular neurons that excreted oxytocin and vasopressin.
Consistent with these findings, Kapoor&Sladek [61] demonstrated
that the alpha(1)-adrenergic agonist phenylephrine increasedvaso-
pressin release in the hypothalamoneurohypophyseal axis. There-
fore, these results suggest that neuronal projections from the A1 to
paraventricular and supraoptic nuclei may be involved in
vasopressin release in response to acute hypernatremia.
Reduced fractional sodium excretion indicates that A1 lesions
impair the capacity of the augmenting glomerular filtration rate,
which is a possible renal mechanism determining the increases in
sodium loss in response to hypertonic NaCl. Several factors may
have contributed to the attenuation of this effect in A1-lesioned
rats. The small pressor responsemight prevent the low natriuresis
that was observed in A1-lesioned rats that had been infused with
HS. This response could also attenuate renal sympathoinhibition
because renal denervation prevents increases in renal sodium
excretion evoked by hypertonic NaCl [19]. We have provided
substantial evidencethat the renal vasodilation and sympathoinhi-
bition that was induced by HS infusion were blunted in animals
that were submitted to A1 noradrenergic neuron lesions [12,17].
In addition, Frithiof et al., [62] have demonstrated that intracer-
ebroventricular administration ofhypertonic NaCl decreasedthe
sympathetic outflow to renal nerves in conscious sheep. Our main
hypothesis states thata reduction in the hypertensive response that
is associated with an attenuation of sympathoinhibition would
reduce the sodium excretion that is induced by hypernatremia in
A1-lesioned rats. To the best of our knowledge, this is the first
statement on the role of A1 noradrenergic lesions in hypertension
and renal sodium excretion responses that are induced by
hypernatremia in non-anesthetized rats.
We conclude that the recruitment of A1 noradrenergic neurons
is essential toadjustthe cardiovascular and renal responses that are
induced by acute changes in the concentration of plasma sodium.
Figure 3. Photomicrography of the nitrocellulose membrane with marking of TH in the MnPO and cortex. Molecular analysis of
noradrenergic neurotransmission of the A1 group of the CVLM region for MnPO with marking for TH (circle) by the Dot Blot technique in sham and
anti-DbH-saporin-treated rats. Photomicrographs of a coronal section of a brain showing withdrawal of the tissue mass from the MnPO (circle) and
cortex (arrows; B).
doi:10.1371/journal.pone.0073187.g003
Table 1. Baseline values for body weight, MAP and HR in
sham and A1-lesioned rats.
Group b.wt. (g) MAP (mm Hg) HR (bpm)
Sham 32365.7 11262.1 34368.4
A1 Lesion 31867.4 11461.9 396613.4{
Values are the means 6 S.E. b.wt., body weight; MAP, mean arterial pressure;
and HR, heart rate. { compared with the sham. p,0.05.
doi:10.1371/journal.pone.0073187.t001
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These noradrenergic neurons are integral parts of pathways that
are involved in the response to hypernatremia because the lack of
these cells results in inefficient responses. Dysfunctions in this
system could contribute to the genesis and aggravation of
cardiovascular and renal diseases that are likely related to renal
sodium retention such as hypertension, cirrhosis and cardiac
failure.
Methods
Animals
All experiments were conducted on adult male Wistar rats (280–
340 g), which were obtained from the central animal house of the
Federal University of Goia´s. Experimental procedures were
designed with strict adherence to the National Institute of
HealthGuidelines for the Care and Use of Laboratory Animals
as approved by the Ethics Committee, Federal University of Goia´s
(protocol number 172/09).
Nanoinjections of anti-DbH-saporin or saporin into the
CVLM
Animals were anaesthetized with halothane (2%; Crista´lia Ltda,
Itapira, SP, Brazil) in O2 and mounted prone in a stereotaxic
apparatus (David Kopf Instruments, Tujunga, CA, USA) that had
its incisor bar 11 mm below the interaural line. After partial
removal of the occipital bone, the meninges covering the dorsal
surface of the brainstem were cut and retracted, and the calamus
scriptorius was visualized. Nanoinjections of anti-DbH-saporin
(0.105 ng.nL21; Advanced Targeting Systems, San Diego, CA,
USA) or an equimolar dose of saporin (0.021 ng.nL21; Advanced
Targeting Systems, San Diego, CA, USA) were made bilaterally at
two levels of the CVLM. For all nanoinjections into the CVLM, a
glass micropipette was positioned as follows: 0.3 mm rostral and
0.3 mm caudal from the calamus scriptorius, 2.0 mm lateral from the
mid-line, and 2.0 mm ventral from the dorsal surface. These co-
ordinates were based on the region of the CVLM consisting of the
A1 group [48]. After nanoinjections, the micropipette was left in
place for 3 min, the incision wasclosed, and the animals were
placed on a heated pad to maintain their body temperature during
recovery. A prophylactic antibiotic dose (penicillin, 60.000 IU N
kg21, i.m. Sigma-Aldrich, St Louis, MO, USA) was injected after
surgery, and the animals were studied 15 days after microinjec-
tions into the CVLM.
Surgical procedures
The rats were anesthetized with 2% halothane (Crista´lia Ltda,
Itapira, SP, Brazil) in O2, andthe right femoral artery of each rat
was cannulated for blood pressure recording. The right femoral
vein was catheterized for drug administration (phenylephrine and
potassium cyanide) and infusion of hypertonic saline (HS), and the
cannulas were led subcutaneously to exit between the scapulae.
Recording of arterial pressure and heart rate
To record the arterial pressure of each rat, an arterial catheter
was connected to a pressure transducer that was attached to a
bridge amplifier (ETH-200; CB Sciences, Dover, NH, USA). The
pulsatile pressure of each rat was recorded continuously with a
PowerLab System (ADInstruments, Colorado Springs, CO, USA),
and the MAP and HR were determined using the pulsatile signal
and Chart software (version 5.5.6; ADInstruments, Colorado
Springs, CO, USA).
Baroreflex and Chemoreflex Tests
A day after surgery, the animals were subjected to baroreflex
and chemoreflex tests through the infusion of phenylephrine (1 mg,
1.5 mg and 2 mg; adrenergic agonist; Sigma-Aldrich, St Louis,
MO, USA) and potassium cyanide (40 mg; Sigma-Aldrich, St
Louis, MO, USA), respectively. All injections were performed with
at least 5 min between each injection or until cardiovascular
parameters returned to baseline.
Infusion of hypertonic saline and blood sampling
To increase the concentration of sodium in the plasma of the
rats, HS (3 M NaCl, 1.8 ml N kg, b.wt., over 1 min) was infused
through the femoral vein cannulas. After infusion with HS, the
cardiovascular parameters were recorded for 90 min, and blood
Figure 4. Baroreceptor sensitivity and chemoreflex response.
Baroreflex sensitivity(BS; A) expressed by changes in the heart rate (HR)
and mean arterial pressure (MAP) that were induced by phenyleprine
infusion in sham and A1-lesioned rats. p,0.05. Changes in MAP (B) and
HR (C) induced by intravenous potassium cyanide infusion.
doi:10.1371/journal.pone.0073187.g004
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Figure 5. Typical examples. Digitized record of cardiovascular responses that were induced by hypertonic saline infusion in sham (A) and A1-
lesioned rats (B). Arterial blood pressure (ABP), mean arterial pressure (MAP), and heart rate (HR).
doi:10.1371/journal.pone.0073187.g005
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samples (0.20 ml each) were withdrawn from the arterial cannula
5 min before and 10, 30, 60 and 90 min after HS infusion. After
each sample was collected, an equal volume of sterile 0.15 M
NaCl was injected to reduce the changes in the extracellular fluid
volume due to sampling. The blood hemoglobin concentration
was measured immediately using a kit from Sigma (Drabkin’s
reagent, kit 525; Sigma-Aldrich, St Louis, MO, USA), and the
remainder of the sample was centrifuged for 5 min at 6000 g. The
plasma was removed and stored at 220uC, and the sodium
concentration of the plasma in the blood was measured using a
flame photometer (model DM6, Digimed, Sa˜o Paulo, SP, Brazil).
Urine Analysis
The A1-lesioned and sham rats were housed in metabolic cages
with free access towater for only 48 h before tests were performed.
On the day of the urinary excretion test, all animals received a
suprapubic massage to induce micturition. After 5 min, the HS
solution was infused, and urine samples were collected in
polypropylene tubes to measure the urinary volume at 30, 60
and 90 min. The concentration of sodium in the urine was
measured using a flame photometer (model DM6, Digimed, Sa˜o
Paulo, Brazil), and the amount of sodium in the urine was
determined by calculating the product of the urine volume and
sodium concentration. The urinary balance was calculated as the
difference between the amounts that were infused and excreted.
During the experiments, the animals had no access to water or
food.
Perfusion, fixation and tissue collection
At the end of the experiments, the animals were profoundly
anesthetized and perfused through the heart with saline (0.15 M
NaCl) followed by a solution of 4% paraformaldehyde (Sigma-
Aldrich, St. Louis, MO, USA) in 0.2 M sodium phosphate buffer
(500 ml at pH 7.4).The brain of each rat was removed and post-
fixed in 4% paraformaldehyde solution for 1–2 h and then
cryoprotected in 30% sucrose solution. Coronal sections of 40 mm
of the brainstem were collected (in 4 serially adjacent sets) and
stored in 0.02 M potassium phosphate-buffered saline (KPBS,
Sigma; pH 7.4).
Immunohistochemistry
Each fourth brainstem section was processed for immunohisto-
chemical detection of TH. The sections were pre-incubated for
15 min in 3% hydrogen peroxide in 0.02 M KPBS followed by a
30-min incubation in 2% normal horse serum (Vector Laborato-
ries Inc., Burlingame, CA, USA) in 0.02 M KPBS. The sections
were incubated overnight at 4uC with mouse monoclonal antibody
(1:2000 dilution, ImmunoStar, Inc., Hudson, WI, USA) in 2%
normal horse serum and Triton X 10% followed by a 1-h
incubation with biotinylated horse anti-mouse IgG (Vector
Laboratories Inc., Burlingame, CA, USA; 1:2000 dilution with
Triton X 10%). After these incubations, the sections were
processed using the avidin–biotin procedure, which utilized Elite
Vectastain reagents (Vector Laboratories Inc., Burlingame, CA,
Figure 6. Effects of A1 noradrenergic neuron lesions on
cardiovascular responses that were induced by hypernatremia.
Effects from hypertonic saline infusion (3 M NaCl, 1.8 ml.Kg21 body
weight) on the mean arterial pressure (MAP; A) and heart rate (HR; B) of
sham and A1-lesioned rats. The bars indicate the moment of hypertonic
saline infusion. *compared with the baseline; { compared with the sham
at the same time point;for both, p , 0.05.
doi:10.1371/journal.pone.0073187.g006
Figure 7. Sodium and blood hemoglobin concentrations in
plasma. Mean 6 S.E.M. of plasma sodium (A) and blood hemoglobin
concentrations (B) at baseline and as a response to HS infusion in sham
and A1-lesioned rats. * different from baseline; { different from sham at
the same time point; for both, p,0.05.
doi:10.1371/journal.pone.0073187.g007
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USA). Diaminobenzidine (DAB; Vector Laboratories Inc., Bur-
lingame, CA, USA) was used to produce a brown, cytoplasmic TH
reaction product. Sections were mounted on slides, dehydrated in
a series of alcohols, cleared in xylene and coverslipped.
Cell counting
Counts of neurons were performed in every fourth medulla
oblongata section (40 of each 160 mm). All immunolabeled
neurons in the ventrolateral medulla (VLM; A1/C1) and nucleus
of the solitary tract (NTS; A2/C2) were counted bilaterally to
quantify the extent of the anti-DbH–saporin-induced lesion. The
neurons were counted at x200 magnification using a Nikon light
microscope (Eclipse Ni-U; Nikon Corporation, Tokyo, Japan).
Dot Blot
Approximately 100 mg of MnPO and cortex brain samples
were macerated in Tris-HCl (50 mM, pH 7.5), andthe samples
were centrifuged at 12.000 rpmsand 4uC for 5 min. The
supernatant was transferred to another tube, and the protein
concentration was estimated using the Bradford method [63]. Fifty
micrograms of each sample was transferred to a nitrocellulose
membrane, andafter a 1-h blocking step in 5% powdered milk that
was diluted in TBS 0.05% with Tween 20, the membrane was
incubated overnight at 4uC with a mouse monoclonal TH
antibody (1:5000 in 1% milk TBS-Tween 20; Immuno Star Inc.,
Hudson, WI, USA). Following 4 washes for 15 min at RT, the
membrane was incubated for 1 h with an anti-mouse antibody
that was coupled to phosphatase (1:2000 in 1% milk TBS-
Tween20), washed again 46and finally revealed using the BCIP/
NBT solution (Amresco LLC, Solon, OH, USA).
Data analysis
The effects of treating with anti-DbH–saporin or saporin on the
number of catecholaminergic medullary neurons are presented as
the means 6 S.E., and cell countings for every section were
compared by one-way ANOVA. Additionally, total cell counting
for the A1, C1, A2 and C2 regions were calculated and compared
between groups using the unpaired Students t-test. Data on
cardiovascular and renal responses and plasma sodium and blood
hemoglobin concentrations were analyzed by two-way analysis of
variance followed by the Newman-Keuls test. The differences in
the baseline levels (Table 1) between the groups were analyzed
using the unpaired Student’s t-test, and a value of P,0.05 was
considered to denote a significant difference.
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